Results 161 to 170 of about 41,389 (199)

Efficacy and safety of treatment regimens for drug-resistant tuberculosis in different regions: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Geng X, Zhang F, Liu R, Zhang F, Li Z, Li L.   +5 more
europepmc   +1 more source

Interim efficacy and safety analysis of the regimen containing delamanid in the treatment of multidrug resistant/rifampicin-resistant/extensively drug-resistant tuberculosis: a single-arm, prospective, monocentric, observational study. [PDF]

BMC Infect Dis
Qin Y, Chen Y, Cai Q.
europepmc   +1 more source

Draft genomes of three XDR <i>Mycobacterium tuberculosis</i> clinical isolates from Morocco. [PDF]

Microbiol Resour Announc
Laatri S, El Kassimi S, Bentaleb EM, El Messaoudi M, Belkadi B, Filali-Maltouf A, Ait Benhassou H.   +6 more
europepmc   +1 more source

Pre-extensively drug-resistant tuberculosis of the spine in a previously healthy young adult: case report. [PDF]

BMC Infect Dis
Schreurs H, Dejaegher J, Decroo T, André E, Lorent N, Henckaerts L.   +5 more
europepmc   +1 more source

Tracking the evolution of an extensively drug-resistant cross-border <i>Mycobacterium tuberculosis</i> cluster, Europe, January 2016 up to August 2025: implications for European surveillance. [PDF]

Euro Surveill
Saluzzo F, Sepulcri C, Zinola A, Di Marco F, Ragazzoni L, Rossi M, Codecasa L, Cirillo DM.   +7 more
europepmc   +1 more source

Prevalence of multidrug-resistant organisms colonizing neonates at a tertiary hospital in Johannesburg, South Africa. [PDF]

J Trop Pediatr
Mntla N, Chibabhai V, Nana T.
europepmc   +1 more source

Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015). [PDF]

BMC Infect Dis
Castello FA, Sosa EJ, Campos J, Monteserin J, Poklepovich T, Palumbo MC, Serral F, Messano J, García LG, Simboli N, Turjanski A, Paul R, López B, Matteo M, Palomino MM, Martí M, Fernández Do Porto D.   +16 more
europepmc   +1 more source